stock
Intensity Therapeutics, Inc. Common stock
NASDAQ | INTS
0.73
USD
$0.00
(0.00%
)At Close (As of Oct 31, 2025)
$64.75M
Market Cap
-
P/E Ratio
-0.82
EPS
$3.40
52 Week High
$0.18
52 Week Low
HEALTHCARE
Sector
INTS Chart
Recent Chart
Price Action
INTS Technicals
INTS Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$25K |
| Total Revenue | $0 |
| Cost Of Revenue | $25K |
| Costof Goods And Services Sold | $25K |
| Operating Income | -$17M |
| Selling General And Administrative | $6.1M |
| Research And Development | $10M |
| Operating Expenses | $17M |
| Investment Income Net | - |
| Net Interest Income | $314K |
| Interest Income | $314K |
| Interest Expense | $0 |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $25K |
| Income Before Tax | -$16M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$16M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$16M |
| Ebitda | -$16M |
| Net Income | -$16M |
Revenue & Profitability
Earnings Performance
INTS Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $4.8M |
| Total Current Assets | $3.4M |
| Cash And Cash Equivalents At Carrying Value | $2.6M |
| Cash And Short Term Investments | $2.6M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $1.4M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $0 |
| Other Current Assets | $773K |
| Other Non Current Assets | - |
| Total Liabilities | $1.9M |
| Total Current Liabilities | $1.8M |
| Current Accounts Payable | $1.2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $28K |
| Total Non Current Liabilities | $110K |
| Capital Lease Obligations | $138K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $138K |
| Other Current Liabilities | $508K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $2.9M |
| Treasury Stock | - |
| Retained Earnings | -$67M |
| Common Stock | $2K |
| Common Stock Shares Outstanding | $14M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$15M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | - |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $6.4M |
| Cashflow From Financing | $2.9M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$16M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$25K |
| Total Revenue | $0 |
| Cost Of Revenue | $25K |
| Costof Goods And Services Sold | $25K |
| Operating Income | -$17M |
| Selling General And Administrative | $6.1M |
| Research And Development | $10M |
| Operating Expenses | $17M |
| Investment Income Net | - |
| Net Interest Income | $314K |
| Interest Income | $314K |
| Interest Expense | $0 |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $25K |
| Income Before Tax | -$16M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$16M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$16M |
| Ebitda | -$16M |
| Net Income | -$16M |
INTS News
INTS Profile
Intensity Therapeutics, Inc. Common stock Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None
EPWK +29.15%
$0.08
YDKG
+21.59%
$0.05
VHAI -17.50%
$0.00
WTO +6.92%
$0.04
HKD +74.55%
$2.95
MSAI +18.18%
$1.56
INTS -44.68%
$0.73
NVDA -0.19%
$202.49
AMZN +9.58%
$244.22
BENF +48.24%
$0.82
PFE +1.48%
$24.65
GETY -6.46%
$1.88
ASST +9.91%
$1.33
DVLT -19.44%
$2.02
ONDS +2.38%
$6.44
BYND +0.30%
$1.65
BURU
+0.26%
$0.33
BTG -9.85%
$4.38
PLUG +1.50%
$2.69
NOK -3.08%
$6.91
MSPR -30.29%
$0.22
T +0.28%
$24.75
CTM +13.59%
$1.17
DNN -1.55%
$3.17
AAPL -0.37%
$270.37
QS +16.78%
$18.44
TSLA +3.74%
$456.56
INTC -0.42%
$39.99
BITF -2.21%
$3.97
ACHR +2.37%
$11.22
AZI +3.38%
$0.09
RIG -1.79%
$3.84
F +0.53%
$13.13
NWL -27.96%
$3.40
AXDX -61.36%
$0.03
RGTI +4.11%
$44.27
SOFI +2.23%
$29.68
GPUS
-7.48%
$0.40
ADTX -12.64%
$0.05
TGE
-53.70%
$0.77
RANI +51.72%
$2.20
LAZR -45.02%
$1.15
CJET -9.39%
$0.04
META -2.71%
$648.35
PLTR +3.04%
$200.47
VZ +2.00%
$39.74
CAN +15.32%
$1.43
NIO +3.42%
$7.25
ADAP -15.14%
$0.05
CMG -2.58%
$31.69
LUMN -0.58%
$10.28
WULF +4.58%
$15.50
MNOV +39.49%
$1.66
KVUE +0.91%
$14.37
VALE +1.68%
$12.09
SNAP +2.63%
$7.80
QUBT +11.62%
$16.71
CCL +1.76%
$28.83
RIVN +4.46%
$13.57
AAL +2.73%
$13.13
CIFR -2.20%
$18.64
WBD +3.83%
$22.45
JOBY +4.77%
$17.34
RXRX -2.30%
$5.52
GRAB +0.50%
$6.01
CLF +1.38%
$12.43
TLRY +3.87%
$1.34
RMBL +60.50%
$3.21
BAC +0.79%
$53.45
GOOGL -0.10%
$281.19
AMCR +0.63%
$7.90
ADD -25.47%
$0.05
ABEV +0.43%
$2.31
QBTS +2.63%
$37.06
ETHD -10.66%
$3.77
BBD -0.29%
$3.38
CABA +46.15%
$3.61
SRM +53.27%
$10.30
AMD +0.50%
$256.12
MSFT -1.51%
$517.80
LAES +7.69%
$7.42
HPE +0.04%
$24.42
MARA +2.87%
$18.27
RIOT -6.21%
$19.78
KDLY +8.92%
$0.92
NAKA
+8.92%
$0.92
BTBT +3.38%
$3.66
DFSC
+20.68%
$5.25
APLD +2.09%
$34.65
KHC +0.61%
$24.73
FI +2.30%
$66.69
GOOG -0.02%
$281.82
MRVL +5.83%
$93.74
WLGS -5.57%
$0.04
SOUN +4.44%
$17.62
IXHL -6.56%
$0.37
FUBO +3.27%
$3.78
NVTS +7.16%
$13.46
ETWO 0.00%
$3.30
DXCM -14.63%
$58.22
EPWK +29.15%
$0.08
YDKG
+21.59%
$0.05
VHAI -17.50%
$0.00
WTO +6.92%
$0.04
HKD +74.55%
$2.95
MSAI +18.18%
$1.56
INTS -44.68%
$0.73
NVDA -0.19%
$202.49
AMZN +9.58%
$244.22
BENF +48.24%
$0.82
PFE +1.48%
$24.65
GETY -6.46%
$1.88
ASST +9.91%
$1.33
DVLT -19.44%
$2.02
ONDS +2.38%
$6.44
BYND +0.30%
$1.65
BURU
+0.26%
$0.33
BTG -9.85%
$4.38
PLUG +1.50%
$2.69
NOK -3.08%
$6.91
MSPR -30.29%
$0.22
T +0.28%
$24.75
CTM +13.59%
$1.17
DNN -1.55%
$3.17
AAPL -0.37%
$270.37
QS +16.78%
$18.44
TSLA +3.74%
$456.56
INTC -0.42%
$39.99
BITF -2.21%
$3.97
ACHR +2.37%
$11.22
AZI +3.38%
$0.09
RIG -1.79%
$3.84
F +0.53%
$13.13
NWL -27.96%
$3.40
AXDX -61.36%
$0.03
RGTI +4.11%
$44.27
SOFI +2.23%
$29.68
GPUS
-7.48%
$0.40
ADTX -12.64%
$0.05
TGE
-53.70%
$0.77
RANI +51.72%
$2.20
LAZR -45.02%
$1.15
CJET -9.39%
$0.04
META -2.71%
$648.35
PLTR +3.04%
$200.47
VZ +2.00%
$39.74
CAN +15.32%
$1.43
NIO +3.42%
$7.25
ADAP -15.14%
$0.05
CMG -2.58%
$31.69
LUMN -0.58%
$10.28
WULF +4.58%
$15.50
MNOV +39.49%
$1.66
KVUE +0.91%
$14.37
VALE +1.68%
$12.09
SNAP +2.63%
$7.80
QUBT +11.62%
$16.71
CCL +1.76%
$28.83
RIVN +4.46%
$13.57
AAL +2.73%
$13.13
CIFR -2.20%
$18.64
WBD +3.83%
$22.45
JOBY +4.77%
$17.34
RXRX -2.30%
$5.52
GRAB +0.50%
$6.01
CLF +1.38%
$12.43
TLRY +3.87%
$1.34
RMBL +60.50%
$3.21
BAC +0.79%
$53.45
GOOGL -0.10%
$281.19
AMCR +0.63%
$7.90
ADD -25.47%
$0.05
ABEV +0.43%
$2.31
QBTS +2.63%
$37.06
ETHD -10.66%
$3.77
BBD -0.29%
$3.38
CABA +46.15%
$3.61
SRM +53.27%
$10.30
AMD +0.50%
$256.12
MSFT -1.51%
$517.80
LAES +7.69%
$7.42
HPE +0.04%
$24.42
MARA +2.87%
$18.27
RIOT -6.21%
$19.78
KDLY +8.92%
$0.92
NAKA
+8.92%
$0.92
BTBT +3.38%
$3.66
DFSC
+20.68%
$5.25
APLD +2.09%
$34.65
KHC +0.61%
$24.73
FI +2.30%
$66.69
GOOG -0.02%
$281.82
MRVL +5.83%
$93.74
WLGS -5.57%
$0.04
SOUN +4.44%
$17.62
IXHL -6.56%
$0.37
FUBO +3.27%
$3.78
NVTS +7.16%
$13.46
ETWO 0.00%
$3.30
DXCM -14.63%
$58.22